ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 204 filers reported holding ARCUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,919,222 | -67.8% | 385,472 | -63.6% | 0.16% | -65.1% |
| Q2 2023 | $21,518,039 | +121.6% | 1,059,480 | +99.0% | 0.47% | +137.7% |
| Q1 2023 | $9,710,629 | +457.4% | 532,381 | +532.0% | 0.20% | +397.5% |
| Q4 2022 | $1,742,166 | -68.0% | 84,244 | -51.1% | 0.04% | -68.3% |
| Q1 2022 | $5,438,000 | +339.3% | 172,300 | +463.1% | 0.13% | +334.5% |
| Q4 2021 | $1,238,000 | +57.1% | 30,600 | +6.6% | 0.03% | +16.0% |
| Q2 2021 | $788,000 | – | 28,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |